ArticleDrug design, development and therapy2014
Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation.
Nobuaki Ochi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it